Proteomic changes of CD4+/CD25+/forkhead box p3+ regulatory T cells in a 30-day rat model of sepsis survival

被引:2
|
作者
Jiao, Yuxia [1 ]
Tan, Siqi [1 ]
Xiong, Junyu [1 ]
机构
[1] Dalian Med Univ, Dept Anesthesiol, Hosp 2, 467 Zhongshan Rd, Dalian 116027, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
sepsis; forkhead box p3; regulatory T cells; recover; survival model; proteome; biological pathways; blood; spleen; HIPPO SIGNALING PATHWAY; IMMUNE DYSFUNCTION; MAPK/ERK PATHWAY; ANIMAL-MODELS; SEPTIC SHOCK; VITAMIN-D; INTEGRIN; FILAMIN; CANCER; IMMUNOSUPPRESSION;
D O I
10.3892/etm.2017.5233
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Sepsis is defined as life threatening organ dysfunction arising from a dysregulated host response to infection. The outcomes of sepsis include early mortality, delayed mortality and recovery, and depend on the inflammatory response. Previous studies have demonstrated that regulatory T cells (Tregs) are important in determining the outcome of sepsis, as their suppressive function serves a role in maintaining immune homeostasis. However, Treg-mediated immunosuppression during the course of sepsis remains unclear and little is known about the survival of patients following diagnosis. Studying the survivors of sepsis may explain the mechanisms of natural recovery. Therefore, a 30-day rat model of sepsis survival was established in the current study. Cluster of differentiation CD4(+)/CD25(+)/forkhead box p3(+) Tregs were isolated from the blood and spleens of rats undergoing cecal ligation and puncture or sham surgery, using flow cytometry. Proteomic analysis was performed using nano high-performance liquid chromatography--mass spectrometry. Several different biological pathways associated with uncommon differentially-expressed proteins were identified in the blood and spleen survivor and sham groups. Extracellular-regulated kinase/mitogen-activated protein kinase, as well as integrin and actin cytoskeletal pathway elements, including Ras-related protein 1b, talin 1 and filamin A, were associated with Tregs in the blood. Pathway elements associated with cell cycle regulators in the B-cell translocation gene family of proteins, tumor necrosis factor receptor superfamily member 4, Hippo signaling, P70-S6 kinase 1, phosphatidylinositol 3-kinase/protein kinase B signaling and 1,25-dihydroxyvitamin D3 biosynthesis were associated with Tregs from the spleen including phosphatase 2A activator regulatory factor 4, histone arginine methyltransferase, CD4, major histocompatibility complex class I antigens, 14-3-3 protein. and nicotinamide adenine dinucleotide phosphate cytochrome P450 reductase. These results explain the mechanism by which Tregs naturally recover and indicates that Tregs in the blood and spleen vary. Differentially-expressed proteins serving a role in these pathways provide additional insight for the identification of new targets for the diagnosis and treatment of sepsis.
引用
收藏
页码:5619 / 5628
页数:10
相关论文
共 50 条
  • [1] The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis
    Wisnoski, Nicholas
    Chung, Chun-Shiang
    Chen, Yaping
    Huang, Xin
    Ayala, Alfred
    SHOCK, 2007, 27 (03): : 251 - 257
  • [2] The peripheral generation of CD4+ CD25+ regulatory T cells
    Akbar, AN
    Taams, LS
    Salmon, M
    Vukmanovic-Stejic, M
    IMMUNOLOGY, 2003, 109 (03) : 319 - 325
  • [3] Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells
    Piper, K. P.
    Karanth, M.
    McLarnon, A.
    Kalk, E.
    Khan, N.
    Murray, J.
    Pratt, G.
    Moss, P. A. H.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 166 (02): : 154 - 163
  • [4] CD25+ CD4+ regulatory T cells in patients with Kawasaki disease
    Furuno, K
    Yuge, T
    Kusuhara, K
    Takada, H
    Nishio, H
    Khajoee, V
    Ohno, T
    Hara, T
    JOURNAL OF PEDIATRICS, 2004, 145 (03): : 385 - 390
  • [5] The role of regulatory CD4+ CD25+ T cells in allergic diseases
    Bellinghausen, I
    Knop, J
    Saloga, J
    ALLERGOLOGIE, 2004, 27 (11) : 444 - 449
  • [6] CD4+ CD25+ regulatory T cells:: towards therapeutic immunomodulation?
    Solomon, B
    M S-MEDECINE SCIENCES, 2002, 18 (11): : 1066 - 1068
  • [7] TGF-beta and CD4+ CD25+ regulatory T cells
    Huber, S
    Schramm, C
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 1014 - 1023
  • [8] CD4+ CD25+ FoxP3+ regulatory T cells in autoimmune diseases
    Valencia, Xavier
    Lipsky, Peter E.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (11): : 619 - 626
  • [9] Relative Resistance of Human CD4+ Memory T Cells to Suppression by CD4+ CD25+ Regulatory T Cells
    Afzali, B.
    Mitchell, P. J.
    Scotta, C.
    Canavan, J.
    Edozie, F. C.
    Fazekasova, H.
    Lord, G. M.
    John, S.
    Barber, L. D.
    Hernandez-Fuentes, M. P.
    Lechler, R. I.
    Lombardi, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (08) : 1734 - 1742
  • [10] Induction of CD4+ CD25+ T Regulatory Cells with CD103 Depletion
    Zikri, Nancy N.
    Schumer, Erin
    Wang, Jiao-Jing
    Gaughan, Alice
    Hadley, Gregg A.
    Moffatt-Bruce, Susan D.
    JOURNAL OF SURGICAL RESEARCH, 2010, 163 (01) : 162 - 168